Device and method for treating ophthalmic diseases
First Claim
Patent Images
1. A method for delivering a biologically active molecule to the eye comprising:
- implanting a capsule periocularly, the capsule comprising a core containing a cellular source of the biologically active molecule and a surrounding biocompatible jacket, the jacket permitting diffusion of the biologically active molecule into the eye, wherein one or more second biologically active molecule is co-delivered to the eye, wherein the one or more second biologically active molecule is selected from the group consisting of anti-angiogenic factors, anti-inflammatory factors, factors retarding cell degeneration, factors promoting cell sparing, and factors promoting cell growth.
5 Assignments
0 Petitions
Accused Products
Abstract
The invention provides a method for delivering biologically active molecules to the eye by implanting biocompatible capsules containing a cellular source of the biologically active molecule. Also provided is a method of treating ophthalmic diseases using biocompatible capsules.
56 Citations
3 Claims
-
1. A method for delivering a biologically active molecule to the eye comprising:
implanting a capsule periocularly, the capsule comprising a core containing a cellular source of the biologically active molecule and a surrounding biocompatible jacket, the jacket permitting diffusion of the biologically active molecule into the eye, wherein one or more second biologically active molecule is co-delivered to the eye, wherein the one or more second biologically active molecule is selected from the group consisting of anti-angiogenic factors, anti-inflammatory factors, factors retarding cell degeneration, factors promoting cell sparing, and factors promoting cell growth. - View Dependent Claims (2, 3)
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeNeurotech USA, Inc. (Woodbrook Group Holdings, Inc.)
-
Original AssigneeNeurotech S.A. (LivaNova Plc)
-
InventorsSpear, Peter D., Tsiarias, William G., Baetge, E. Edward, Hammang, Joseph P.
-
Primary Examiner(s)AZPURU, CARLOS A
-
Application NumberUS10/224,521Publication NumberTime in Patent Office455 DaysField of Search424/427, 623/4.1US Class Current424/427CPC Class CodesA61F 9/0017 implantable in, or in conta...A61K 9/0051 Ocular inserts, ocular impl...
